Sales rose +11% (organic: +2%) to €11,036m and the gross profit margin improved from 51.3% to 55.1%. EBITDA was up +15% to €2,355m and net profit attributable to shareholders increased +21% to €999m.
29 Oct 2015
Strong sales growth in Q3, but the FX push will be more moderate
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Strong sales growth in Q3, but the FX push will be more moderate
Bayer AG (BAYN:WBO) | 0 0 0.5% | Mkt Cap: 80,975m
- Published:
29 Oct 2015 -
Author:
Martin Schnee -
Pages:
3
Sales rose +11% (organic: +2%) to €11,036m and the gross profit margin improved from 51.3% to 55.1%. EBITDA was up +15% to €2,355m and net profit attributable to shareholders increased +21% to €999m.